ABVAX | VIVIX | ABVAX / VIVIX | |
Total Expense Ratio | 0.89 | 0.04 | 2,225% |
Annual Report Gross Expense Ratio | 0.89 | 0.04 | 2,225% |
Fund Existence | 24 years | 27 years | - |
Gain YTD | 9.150 | 7.866 | 116% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 435M | 203B | 0% |
Annual Yield % from dividends | 0.93 | 2.11 | 44% |
Returns for 1 year | 1.56 | 7.74 | 20% |
Returns for 3 years | 18.07 | 36.61 | 49% |
Returns for 5 years | 43.48 | 70.16 | 62% |
Returns for 10 years | 49.71 | 131.61 | 38% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBBL | 49.16 | 0.97 | +2.02% |
BondBloxx BBB Rated 10+ Yr Corp Bd ETF | |||
ABLG | 30.32 | 0.26 | +0.87% |
Abacus FCF International Leaders ETF | |||
NBXG | 14.75 | 0.05 | +0.34% |
Neuberger Berman Next Generation Connectivity Fund | |||
QID | 23.57 | -0.03 | -0.13% |
ProShares UltraShort QQQ | |||
QARP | 56.38 | -0.17 | -0.30% |
Xtrackers Russell 1000 US QARP ETF |